Drug
Ulodesine
Ulodesine: highest development phase Phase 2, developed by BioCryst Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- BioCryst Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| ulodesine NCT01265264 | Phase 2 | Gout |
| Ulodesine (BCX4208) 5 mg NCT01407874 | Phase 2 | Gout |
Latest
No recent events.
Follow Ulodesine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.